Drug or treatment
Poseltinib clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Poseltinib that are recruiting, in South Korea. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Poseltinib (NB02) alone for relapsed or refractory non-Hodgkin lymphoma
This trial tests oral poseltinib (NB02) to see if it is safe and shows anti-lymphoma activity in adults 19–80 with relapsed or refractory follicular, mantle cell, or marginal zone lymphoma after at least two prior treatments.
-
Combination therapy for relapsed or refractory primary CNS lymphoma
This study is testing a new combination of medications to see if it can help people with relapsed or hard-to-treat primary central nervous system lymphoma feel better.
Quick answers
How many clinical trials of Poseltinib are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.